No one can say for a fact what the FY18 guidance will be so can't say if it's factored into its share price.
In my opinion though i think most of that is already factored in based on some numbers I've run including the massive ramp up in production synlait will be doing in FY 18.... but you never know there could be some positive surprises from the US/UK growth and others such as expanding into new market or products which no one really knows.
Getting so close, page-10
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.99 |
Change
-0.120(1.69%) |
Mkt cap ! $5.053B |
Open | High | Low | Value | Volume |
$7.00 | $7.07 | $6.96 | $10.80M | 1.545M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 13394 | $6.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.99 | 4946 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1658 | 6.950 |
1 | 144 | 6.910 |
2 | 301 | 6.850 |
1 | 10000 | 6.810 |
5 | 5678 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
7.000 | 2777 | 2 |
7.080 | 3000 | 1 |
7.100 | 2044 | 2 |
7.120 | 2248 | 2 |
7.130 | 250 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
A2M (ASX) Chart |